Tumor Volume Reduction After Gemcitabine Plus Cisplatin Induction Chemotherapy in Locally Advanced Nasopharyngeal Cancer: Comparison with Paclitaxel and Cisplatin Regimens

BACKGROUND: Gemcitabine plus cisplatin (GP) is a novel regimen of induction chemotherapy (IC) for treating locoregional advanced nasopharyngeal cancer (NPC). This retrospective study aimed to compare the efficacy of GP and TP (paclitaxel plus cisplatin) regimens in tumor volume reduction after IC. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Li, Liao, Wenjun, Xu, Peng, Li, Baisen, Wen, Hao, Zhang, Shichuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2018
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237045/
https://www.ncbi.nlm.nih.gov/pubmed/30406770
http://dx.doi.org/10.12659/MSM.909736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237045/
https://www.ncbi.nlm.nih.gov/pubmed/30406770
http://dx.doi.org/10.12659/MSM.909736

Ejemplares similares